Pronunciation: in greh' zah
Generic name: valbenazine [ val-BEN-a-zeen ]
Dosage form: capsule (40 mg, 60 mg, 80 mg)
Drug class: VMAT2 inhibitors

Medically reviewed by Melisa Puckey, BPharm. Last updated on Aug 23, 2023.

What is Ingrezza?

Ingrezza (valbenazine) is used to treat tardive dyskinesia and chorea associated with Huntington's disease (HD), which are both body movement disorders. Ingrezza works by decreasing the amount of dopamine, in the nerve endings in the brain, which helps control body movements. Ingrezza is from a class of medicines called VMAT2 inhibitors, as it inhibits the vesicular monoamine transporter 2 (VMAT2) in neurons. This medicine controls the symptoms of movement disorders but does not cure the conditions.

Tardive dyskinesia is a nervous system disorder that causes repetitive, uncontrolled muscle movements, usually in the face (chewing, lip smacking, frowning, tongue movement, blinking, or eye movement). Tardive dyskinesia is often caused by long-term treatment with certain psychiatric medications. Chorea is a movement disorder that results in sudden involuntary movements. It can be caused by Huntington's disease (an inherited disease that causes the progressive breakdown of nerve cells in the brain). 

Ingrezza became an FDA-approved medicine on April 11, 2017, for adults with tardive dyskinesia, and on August 18, 2023, and it became approved for the treatment of chorea associated with Huntington's disease. The chorea associated with Huntington's disease approval was based on positive results from the  KINECT-HD Phase 3 study and the ongoing KINECT-HD2 that showed an improvement in chorea severity with a statistically significant greater improvement in Total Maximal Chorea (TMC) score when compared to placebo.

Ingrezza side effects

Common Ingrezza side effects 

• headache, dizziness, drowsiness;
• problems with balance or coordination;
• dry mouth;
• feeling restless;
• constipation; or
• blurred vision.

Serious Ingrezza side effects 

Also see Warnings section below.

Get emergency medical help if you have signs of an allergic reaction to this medicine: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

• extreme drowsiness;
• fast, slow, or uneven heartbeats;
• pounding heartbeats or fluttering in your chest;
• shortness of breath; or
• a light-headed feeling, like you might pass out; or
• Parkinson-like symptoms - tremors, shaking, stiffness, problems with balance or walking.

This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Related/similar drugs

amantadine, pyridoxine, vitamin e, Austedo, tetrabenazine, valbenazine, Austedo XR

Warnings

This mediicne can cause:

Depression and suicidal ideation and behavior are observed in patients with Huntington’s disease.

Hypersensitivity, including angioedema, may occur. Treatment should be discontinued if this occurs.

Somnolence and sedation may impair the patient’s ability to drive or operate hazardous machinery.

QT Prolongation: There may be an increase in QT interval. Usage should be avoided in patients with congenital long QT syndrome or arrhythmias associated with prolonged QT interval.

Neuroleptic Malignant Syndrome (NMS) may occur. Treatment should be discontinued if this syndrome is observed.

Parkinsonism: Some patients have reported Parkinson-like symptoms, including severe cases, during the postmarketing period. The dose of this medicine should be reduced or discontinued if clinically significant Parkinson-like signs or symptoms develop.

Before taking this medicine

You should not use this medicine if you are allergic to valbenazine or any ingredients contained in this medicine, click here for a full list of ingredients

To make sure this medicine is safe for you, tell your doctor if you have ever had:

• heart disease;
• long QT syndrome or other heart rhythm disorder;
• congestive heart failure;
• a heart attack;
• liver disease; or
• kidney disease.

Pregnancy

Ingrezza may cause fetal harm. Tell your doctor if you are pregnant, become pregnant, or plan to become pregnant.

Breastfeeding

Do not breastfeed while using this medicine and for at least 5 days after your last dose.

How should I take Ingrezza?

The usual dose of Ingrezza is once a day with or without food.

Do not stop taking this medicine without first asking your doctor.

Take this medicine exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Your heart function may need to be checked using an electrocardiograph or ECG (sometimes called an EKG).

Dosing information

Usual Adult Dose for Tardive Dyskinesia:

Initial Dose: 40 mg orally once a day

Maintenance Dose: Increase to 80 mg orally once a day after one week at the initial dose; however, a continuation of the initial dose may be considered for some patients.

Usual Adult Dose for Chorea associated with Huntington’s disease:

Initial dose: 40 mg once daily.

Maintenance Dose: Increase the dose in 20 mg increments every two weeks to the recommended dosage of 80 mg once daily. 

Comments:

• Administer with or without food.
• The recommended dosage for patients with moderate or severe hepatic impairment is 40 mg once daily.
• The recommended dosage for known CYP2D6 poor metabolizers is 40 mg once daily.

Ingrezza capsules are available as 40 mg, 60 mg, and 80 mg.

What other drugs will affect Ingrezza?

Other drugs may interact with this medicine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

It is important to tell your doctor if you take any of these medicines.

• Monoamine oxidase inhibitors (MAOIs).
• Strong CYP3A4 inducers 
• Strong CYP3A4 inhibitors 
• Strong CYP2D6 inhibitors 

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What to avoid

Valbenazine may impair your thinking or reactions. Avoid driving or hazardous activity until you know how this medicine will affect you. Dizziness or drowsiness can cause falls, accidents, or severe injuries.

Ingredients

Active ingredient: valbenazine

Inactive ingredients: 40 mg capsule, 60 mg capsule, 80 mg capsule: hypromellose, isomalt, magnesium stearate, pregelatinized starch, and silicified microcrystalline cellulose. The capsule shells contain candurin silver fine, FD&C Blue#1, FD&C Red#40, and gelatin.

Storage

Store at 59°F to 86°F (15°C to 30°C).

Company

Distributed by: Neurocrine Biosciences, Inc., San Diego, CA 92130, U.S.A.

Popular FAQ

More FAQ

• Austedo vs Ingrezza: How do they compare?

View more FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer